Weghofer M, Thomas W R, Kronqvist M, Mari A, Purohit A, Pauli G, Horak F, Grönlund H, van Hage M, Valenta R, Vrtala S
Division of Immunopathology, Department of Pathophysiology, Centre for Physiology and Pathophysiology, Medical University of Vienna, Austria.
Eur J Clin Invest. 2008 Dec;38(12):959-65. doi: 10.1111/j.1365-2362.2008.02048.x.
House dust mites (HDM) Dermatophagoides pteronyssinus are a frequent indoor allergen source. Our aim was to determine the frequencies of IgE reactivity to purified HDM allergen molecules in mite allergic patients from different parts of Europe in order to establish an allergen panel for diagnosis of HDM allergy.
Populations of D. pteronyssinus-allergic patients from Austria (n = 56), France (n = 55), Italy (n = 67) and Sweden (n = 65) and storage mite allergic patients from Sweden (n = 31) were analysed for IgE reactivity to eight purified natural (n) and recombinant (r) D. pteronyssinus allergens (nDer p 1, rDer p 2, nDer p 4, rDer p 5, rDer p 7, rDer p 8, rDer p 10 and rDer p 14) in RAST-based dot blot assays.
Using a combination of Der p 1 and Der p 2, at least 97% of the D. pteronyssinus-allergic patients could be diagnosed in each of the HDM allergic populations. However, more than 50% of the patients also reacted with other allergens and significant variabilities regarding the frequencies of IgE reactivity to individual allergen molecules were found. Patients with a predominant storage mite allergy showed none or only very weak IgE reactivity to purified D. pteronyssinus allergens.
Purified Der p 1 and Der p 2 are sufficient for the diagnosis of > or = 97% of D. pteronyssinus allergic patients in Europe, but other allergens may also play an important role for the diagnosis and treatment of HDM allergy.
屋尘螨是常见的室内过敏原来源。我们的目的是确定来自欧洲不同地区的螨过敏患者中对纯化的屋尘螨过敏原分子的IgE反应频率,以便建立用于诊断屋尘螨过敏的过敏原组合。
对来自奥地利(n = 56)、法国(n = 55)、意大利(n = 67)和瑞典(n = 65)的屋尘螨过敏患者群体以及来自瑞典的储藏螨过敏患者群体(n = 31)进行分析,采用基于RAST的斑点印迹法检测其对8种纯化的天然(n)和重组(r)屋尘螨过敏原(nDer p 1、rDer p 2、nDer p 4、rDer p 5、rDer p 7、rDer p 8、rDer p 10和rDer p 14)的IgE反应。
使用Der p 1和Der p 2的组合,在每个屋尘螨过敏群体中至少97%的屋尘螨过敏患者能够被诊断出来。然而,超过50%的患者也对其他过敏原产生反应,并且发现个体过敏原分子的IgE反应频率存在显著差异。以储藏螨过敏为主的患者对纯化的屋尘螨过敏原无反应或只有非常微弱的反应。
纯化的Der p 1和Der p 2足以诊断欧洲97%及以上的屋尘螨过敏患者,但其他过敏原在屋尘螨过敏的诊断和治疗中也可能起重要作用。